Table 2.
Prognostic Factor | Recurrence-Free Survival | ||
---|---|---|---|
p | HR 1 | 95%-CI 2 | |
Pedicle clamping (Pringle) | 0.017 | 0.67 | 0.48–0.93 |
>3 hepatic metastases | 0.011 | 1.63 | 1.12–2.36 |
Allogeneic blood transfusion | 0.002 | 1.05 3 | 1.02–1.08 |
Charlson co-morbidity index | 0.014 | 1.23 | 1.04–1.45 |
Positive resection margins | 0.003 | 2.08 | 1.29–3.34 |
Overall Survival | |||
p | HR 1 | 95%-CI 2 | |
Age > 70 years | 0.034 | 1.43 | 1.03–1.98 |
Pedicle clamping (Pringle) | 0.009 | 0.60 | 0.41–0.88 |
>3 hepatic metastases | 0.012 | 1.68 | 1.12–2.51 |
Allogeneic blood transfusion | 0.001 | 1.06 3 | 1.02–1.10 |
Charlson co-morbidity index | 0.009 | 1.30 | 1.07–1.57 |
Positive resection margins | <0.001 | 3.18 | 1.92–5.27 |
1 HR: Hazard Ratio; 2 95%-CI: 95% confidence-interval; 3 HR for the number of ABT-units.